Fullerene Derivatives as Lung Cancer Cell Inhibitors: Investigation of Potential Descriptors Using QSAR Approaches

Hung-Jin Huang,1,2 Olga A Kraevaya,3,4 Ilya I Voronov,4 Pavel A Troshin,3,4 Shan-hui Hsu1,2,5 1Institute of Polymer Science and Engineering, National Taiwan University, Taipei, Taiwan; 2Institute of Cellular and System Medicine, National Health Research Institutes, Miaoli, Taiwan; 3Skolkovo Institut...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Huang HJ, Kraevaya OA, Voronov II, Troshin PA, Hsu S
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/5ee83b16a01d4c11908146d5c28abb1f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5ee83b16a01d4c11908146d5c28abb1f
record_format dspace
spelling oai:doaj.org-article:5ee83b16a01d4c11908146d5c28abb1f2021-12-02T09:56:20ZFullerene Derivatives as Lung Cancer Cell Inhibitors: Investigation of Potential Descriptors Using QSAR Approaches1178-2013https://doaj.org/article/5ee83b16a01d4c11908146d5c28abb1f2020-04-01T00:00:00Zhttps://www.dovepress.com/fullerene-derivatives-as-lung-cancer-cell-inhibitors-investigation-of--peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Hung-Jin Huang,1,2 Olga A Kraevaya,3,4 Ilya I Voronov,4 Pavel A Troshin,3,4 Shan-hui Hsu1,2,5 1Institute of Polymer Science and Engineering, National Taiwan University, Taipei, Taiwan; 2Institute of Cellular and System Medicine, National Health Research Institutes, Miaoli, Taiwan; 3Skolkovo Institute of Science and Technology, Moscow, Russian Federation; 4Institute for Problems of Chemical Physics of Russian Academy of Sciences, Chernogolovka, Russian Federation; 5Research and Development Center for Medical Devices, National Taiwan University, Taipei, TaiwanCorrespondence: Shan-hui HsuInstitute of Polymer Science and Engineering, National Taiwan University, No. 1, Sec. 4 Roosevelt Road, Taipei 10617, TaiwanTel +886-2-3366-5313Fax +886-2-3366-5237Email shhsu@ntu.edu.twPavel A TroshinInstitute for Problems of Chemical Physics of Russian Academy of Sciences, Chernogolovka 142432, Russian FederationTel +7 496522-1418Fax +7 496515-5420Email troshin2003@inbox.ruBackground: Nanotechnology-based strategies in the treatment of cancer have potential advantages because of the favorable delivery of nanoparticles into tumors through porous vasculature.Materials and Methods: In the current study, we synthesized a series of water-soluble fullerene derivatives and observed their anti-tumor effects on human lung carcinoma A549 cell lines. The quantitative structure–activity relationship (QSAR) modeling was employed to investigate the relationship between anticancer effects and descriptors relevant to peculiarities of molecular structures of fullerene derivatives.Results: In the QSAR regression model, the evaluation results revealed that the determination coefficient r2 and leave-one-out cross-validation q2 for the recommended QSAR model were 0.9966 and 0.9246, respectively, indicating the reliability of the results. The molecular modeling showed that the lack of chlorine atom and a lower number of aliphatic single bonds in saturated hydrocarbon chains may be positively correlated with the lung cancer cytotoxicity of fullerene derivatives. Synthesized water-soluble fullerene derivatives have potential functional groups to inhibit the proliferation of lung cancer cells.Conclusion: The guidelines obtained from the QSAR model might strongly facilitate the rational design of potential fullerene-based drug candidates for lung cancer therapy in the future.Keywords: water-soluble fullerene derivatives, non-small cell lung cancer, cytotoxicity, machine learning, QSAR  Huang HJKraevaya OAVoronov IITroshin PAHsu SDove Medical Pressarticlewater-soluble fullerene derivativesnon-small cell lung cancercytotoxicitymachine learningqsarMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 15, Pp 2485-2499 (2020)
institution DOAJ
collection DOAJ
language EN
topic water-soluble fullerene derivatives
non-small cell lung cancer
cytotoxicity
machine learning
qsar
Medicine (General)
R5-920
spellingShingle water-soluble fullerene derivatives
non-small cell lung cancer
cytotoxicity
machine learning
qsar
Medicine (General)
R5-920
Huang HJ
Kraevaya OA
Voronov II
Troshin PA
Hsu S
Fullerene Derivatives as Lung Cancer Cell Inhibitors: Investigation of Potential Descriptors Using QSAR Approaches
description Hung-Jin Huang,1,2 Olga A Kraevaya,3,4 Ilya I Voronov,4 Pavel A Troshin,3,4 Shan-hui Hsu1,2,5 1Institute of Polymer Science and Engineering, National Taiwan University, Taipei, Taiwan; 2Institute of Cellular and System Medicine, National Health Research Institutes, Miaoli, Taiwan; 3Skolkovo Institute of Science and Technology, Moscow, Russian Federation; 4Institute for Problems of Chemical Physics of Russian Academy of Sciences, Chernogolovka, Russian Federation; 5Research and Development Center for Medical Devices, National Taiwan University, Taipei, TaiwanCorrespondence: Shan-hui HsuInstitute of Polymer Science and Engineering, National Taiwan University, No. 1, Sec. 4 Roosevelt Road, Taipei 10617, TaiwanTel +886-2-3366-5313Fax +886-2-3366-5237Email shhsu@ntu.edu.twPavel A TroshinInstitute for Problems of Chemical Physics of Russian Academy of Sciences, Chernogolovka 142432, Russian FederationTel +7 496522-1418Fax +7 496515-5420Email troshin2003@inbox.ruBackground: Nanotechnology-based strategies in the treatment of cancer have potential advantages because of the favorable delivery of nanoparticles into tumors through porous vasculature.Materials and Methods: In the current study, we synthesized a series of water-soluble fullerene derivatives and observed their anti-tumor effects on human lung carcinoma A549 cell lines. The quantitative structure–activity relationship (QSAR) modeling was employed to investigate the relationship between anticancer effects and descriptors relevant to peculiarities of molecular structures of fullerene derivatives.Results: In the QSAR regression model, the evaluation results revealed that the determination coefficient r2 and leave-one-out cross-validation q2 for the recommended QSAR model were 0.9966 and 0.9246, respectively, indicating the reliability of the results. The molecular modeling showed that the lack of chlorine atom and a lower number of aliphatic single bonds in saturated hydrocarbon chains may be positively correlated with the lung cancer cytotoxicity of fullerene derivatives. Synthesized water-soluble fullerene derivatives have potential functional groups to inhibit the proliferation of lung cancer cells.Conclusion: The guidelines obtained from the QSAR model might strongly facilitate the rational design of potential fullerene-based drug candidates for lung cancer therapy in the future.Keywords: water-soluble fullerene derivatives, non-small cell lung cancer, cytotoxicity, machine learning, QSAR  
format article
author Huang HJ
Kraevaya OA
Voronov II
Troshin PA
Hsu S
author_facet Huang HJ
Kraevaya OA
Voronov II
Troshin PA
Hsu S
author_sort Huang HJ
title Fullerene Derivatives as Lung Cancer Cell Inhibitors: Investigation of Potential Descriptors Using QSAR Approaches
title_short Fullerene Derivatives as Lung Cancer Cell Inhibitors: Investigation of Potential Descriptors Using QSAR Approaches
title_full Fullerene Derivatives as Lung Cancer Cell Inhibitors: Investigation of Potential Descriptors Using QSAR Approaches
title_fullStr Fullerene Derivatives as Lung Cancer Cell Inhibitors: Investigation of Potential Descriptors Using QSAR Approaches
title_full_unstemmed Fullerene Derivatives as Lung Cancer Cell Inhibitors: Investigation of Potential Descriptors Using QSAR Approaches
title_sort fullerene derivatives as lung cancer cell inhibitors: investigation of potential descriptors using qsar approaches
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/5ee83b16a01d4c11908146d5c28abb1f
work_keys_str_mv AT huanghj fullerenederivativesaslungcancercellinhibitorsinvestigationofpotentialdescriptorsusingqsarapproaches
AT kraevayaoa fullerenederivativesaslungcancercellinhibitorsinvestigationofpotentialdescriptorsusingqsarapproaches
AT voronovii fullerenederivativesaslungcancercellinhibitorsinvestigationofpotentialdescriptorsusingqsarapproaches
AT troshinpa fullerenederivativesaslungcancercellinhibitorsinvestigationofpotentialdescriptorsusingqsarapproaches
AT hsus fullerenederivativesaslungcancercellinhibitorsinvestigationofpotentialdescriptorsusingqsarapproaches
_version_ 1718397883945844736